daunorubicin hydrochloride injection powder for solution
halison pharmaceuiticals usa, inc - daunorubicin hydrochloride (unii: ud984i04lz) (daunorubicin - unii:zs7284e0zp) - daunorubicin 20 mg in 4 ml
zondan solution for injection
incepta pharmaceuticals limited - ondansetron (ondansetron hydrochloride dihydrate) - solution for injection - 2mg/ml
vyxeos liposomal (previously known as vyxeos)
jazz pharmaceuticals ireland limited - daunorubicin hydrochloride, cytarabine - leukemia, myeloid, acute - antineoplastic agents - vyxeos liposomal is indicated for the treatment of adults with newly diagnosed, therapy-related acute myeloid leukaemia (t-aml) or aml with myelodysplasia-related changes (aml-mrc).
daunorubicin hydrochloride for injection powder for solution
teva canada limited - daunorubicin (daunorubicin hydrochloride) - powder for solution - 20mg - daunorubicin (daunorubicin hydrochloride) 20mg - antineoplastic agents
daunorubicin injectable solution
generic medical partners inc - daunorubicin (daunorubicin hydrochloride) - solution - 20mg - daunorubicin (daunorubicin hydrochloride) 20mg - antineoplastic agents
daunorubicin injectable solution
generic medical partners inc - daunorubicin (daunorubicin hydrochloride) - solution - 50mg - daunorubicin (daunorubicin hydrochloride) 50mg - antineoplastic agents
daunorubicin hydrochloride injection solution
hikma canada limited - daunorubicin (daunorubicin hydrochloride) - solution - 20mg - daunorubicin (daunorubicin hydrochloride) 20mg
xylocaine 1.5% 375mg/25ml injection ampoule
astrazeneca pty ltd - lignocaine hydrochloride anhydrous -
daunorubicin 20mg powder for solution for infusion vials
zentiva pharma uk ltd - daunorubicin hydrochloride - powder for solution for infusion - 20mg
daunorubicin injection 20 mg/10 ml (1)
pfizer (perth) pty ltd - daunorubicin hydrochloride, quantity: 2.14 mg/ml - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; sodium hydroxide; water for injections - - acute lymphocytic (lymphoblastic) leukaemia. daunorubicin is usually reserved for use in cases shown to be resistant to other drugs. however, combined treatment with daunorubicin, vincristine and a steroid has been used in the early stages of the disease. - acute myeloblastic leukaemia. daunorubicin has been used in all stages, alone or in combination with other cytotoxic agents e.g., cytarabine. - disseminated solid tumours. daunorubicin has been investigated for use in these tumours and found to be effective in some cases of disseminated neuroblastoma and rhabdomyosarcoma.